Lymphocyte cytotoxicity to cultured rat liver cells in patients with chronic liver diseases.

Microcytotoxicity assay revealed that peripheral bloof lymphocytes from patients with chronic active hepatitis were cytotoxic against cultured rat liver cells established by Coon in 1968. Non E-rosette forming cells were cytotoxic in 26 of 28 patients (93%) with chronic active hepatitis, whereas E-rosette forming cells were cytotoxic in only 1 of them. Either an addition of 10 microgram/well of aggregated IgG to non E-rosette forming cell culture or a preincubation of non E-rosette forming cells with 100 microgram/ml of aggregated IgG significantly reduced the cytotoxicity from 62.9 +/- 12.8% to 32.8 +/- 11.6% or to 25.6 +/- 11.3% (p less than 0.001). An addition of antihuman IgG/Fc also reduced the cytotoxicity to 37.4 +/- 17.2%. Significant cytotoxicity of positively selected EA-rosette forming cells was observed in 4 of 10 patients with chronic active hepatitis and that of positively selected EAC-rosette forming cells was demonstrated in 3, whereas in any of these patients neither non EA-rosette forming cells nor non EAC-rosette forming cells were cytotoxic. Cultured liver cells used in this study were seen to possess insoluble liver specific antigen on their surface membranes, but not soluble liver specific lipoprotein of Meyer zum Büschenfelde, by using an indirect immunofluorescence technique. These results suggested that effector cells are Fc-receptor-bearing cells and that the mechanism of the reaction may be mediated in an antibody-dependent cell-mediated reaction directed against insoluble liver specific membrane antigen(s) rather than soluble one.

[1]  A. Nonomura,et al.  Antibody-dependent cell-mediated cytotoxicity and hepatocyte membrane-fixed IgG in chronic active hepatitis. , 1978, Gastroenterology.

[2]  A. Nonomura,et al.  Leucocyte migration inhibition with inner and outer membranes of mitochondria and insoluble hepatocyte surface membranes prepared from rat liver in patients with chronic hepatitis and cirrhosis. , 1976, Clinical and experimental immunology.

[3]  P. Lobo,et al.  An appraisal of Fc receptors on human peripheral blood B and L lymphocytes. , 1976, Journal of immunology.

[4]  E. Dickson,et al.  Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. , 1976, Gastroenterology.

[5]  S. Sherlock PREDICTING PROGRESSION OF ACUTE TYPE-B HEPATITIS TO CHRONICITY , 1976, The Lancet.

[6]  R. M. Austin,et al.  Inhibition by rheumatoid factor, anti-FC, and staphylococcal protein A of antibody-dependent cell-mediated cytolysis against Herpes simplex virus-infected cells. , 1976, Journal of immunology.

[7]  Roger Williams,et al.  ANTIBODY-DEPENDENT CELL-MEDIATED (K CELL) CYTOTOXICITY AGAINST ISOLATED HEPATOCYTES IN CHRONIC ACTIVE HEPATITIS , 1976, The Lancet.

[8]  R. Herberman,et al.  Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. , 1975, Journal of the National Cancer Institute.

[9]  F. Chisari,et al.  Immunological aspects of hepatitis B virus infection. , 1975, The American journal of the medical sciences.

[10]  A. Eddleston,et al.  Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases. , 1975, Clinics in gastroenterology.

[11]  K. Isselbacher,et al.  Cell-mediated immunity in acute and chronic hepatitis. , 1975, The Journal of clinical investigation.

[12]  K. Isselbacher,et al.  Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Zuckerman,et al.  Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. , 1975, British medical journal.

[14]  F. Paronetto,et al.  Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture. , 1975, Clinical and experimental immunology.

[15]  Roger Williams,et al.  Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis. , 1974, Lancet.

[16]  Roger Williams,et al.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis , 1974, Nature.

[17]  C. Parish,et al.  The lymphocyte surface. I. Relation between Fc receptors, C'3 receptors and surface immunoglobulin , 1974, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[18]  J. Cerottini,et al.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. , 1974, Advances in immunology.

[19]  G. de Thé,et al.  Separation of human lymphocytes forming spontaneous rosettes with sheep erythrocytes. , 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[20]  H. Wigzell,et al.  Lymphocyte Mediated Cytotoxicity in Vitro. Induction and Inhibition by Humoral Antibody and Nature of Effector Cells , 1972, Transplantation reviews.

[21]  A. Eddleston,et al.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. , 1972, Lancet.

[22]  P. Bacon,et al.  Cell-mediated immune reactivity in liver disease , 1972, Gut.

[23]  S. Sherlock,et al.  Cellular immunity and hepatitis-associated, Australia antigen liver disease. , 1972, Lancet.

[24]  A. Eddleston,et al.  Cell-mediated Immune Responses in Chronic Liver Diseases , 1972, British medical journal.

[25]  Meyer zum Büschenfelde,et al.  Liver specific antigens. Purification and characterization. , 1972, Clinical and experimental immunology.

[26]  J. Nielsen,et al.  Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. , 1971, The New England journal of medicine.

[27]  J. Sprent,et al.  Interaction between lymphocytes in immune responses. , 1971, Cellular immunology.

[28]  E. Klein,et al.  A MICROASSAY FOR CELL-MEDIATED IMMUNITY , 1970, Transplantation.

[29]  M. Spirtes,et al.  An improved, reproducible method opreparing rat liver plasma cell membranes in buffered isotonic sucrose. , 1969, Biochimica et biophysica acta.

[30]  B. Waksman,et al.  CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITY , 1968, The Journal of experimental medicine.

[31]  B. Waksman,et al.  CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITY , 1968, The Journal of experimental medicine.

[32]  H. Coon CLONAL CULTURE OF DIFFERENTIATED RAT LIVER CELLS , 1968 .